50% off Premium Yearly

NYSE:CVS
This summary was created by AI, based on 9 opinions in the last 12 months.
CVS Health Corp has garnered mixed reviews from experts, reflecting a complex outlook for the company. While recent earnings exceeded expectations and led to a significant share price increase, analysts remain cautious due to underlying challenges in its Caremark business and uncertainties surrounding visibility in earnings. The comparison with higher-quality growth stocks suggests that CVS may have more execution risk, even as its valuation appears cheaper relative to competitors. The company's shift towards a managed care model and the impact of its drugstore segment raises questions about its long-term performance. Overall, CVS could be a compelling option within its sector, especially when considering the potential for recovery and improvements in management strategy.
Approaching an all time high. Seasonally they have strength from mid-July until beginning of October. Looks like an interesting opportunity. It is in a trading range. If it breaks its support you may want to put a stop just below that.